Company Name
MEI Pharma Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US55279B2025
CIK:
0001262104
CUSIP:
572322303
Currency:
USD
Full Time Employees:
28
Phone:
858 369 7100
Website:
https://meipharma.com
Fiscal Year End:
June
IPO Date:
Dec 19, 2003
Description:
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
Address:
9920 Pacific Heights Blvd., San Diego, CA, United States, 92121